FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

8993611000001100: Clarithromycin 250mg tablets (Sandoz Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21258101000001118 Clarithromycin 250mg tablets (Sandoz Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21258201000001113 Clarithromycin 250mg tablets (Sandoz Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clarithromycin 250mg tablets (Sandoz Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) Is a Product containing precisely clarithromycin 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) Has active ingredient Clarithromycin false Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) Has specific active ingredient Clarithromycin true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Clarithromycin 250mg tablets (Sandoz Ltd) 14 tablet 2 x 7 tablets Is pack of False Clarithromycin 250mg tablets (Sandoz Ltd) Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Sandoz Ltd) 14 tablet 2 x 7 tablets Has AMP True Clarithromycin 250mg tablets (Sandoz Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start